Thank you for your interest in clinical trials for Endocrine Cancer Please click "Search" to find Endocrine Cancer clinical trials and medical research studies.If you receive too many study listings you may enter your zip code to find the locations closest to you.
Your search returned no results. Get alerts when studies become available.
Your search returned 26 studies. (Get alerts for new studies):Detection and Treatment of Endocrine Abnormalities in Childhood Cancer SurvivorsConditions: Hypopituitarism - Hypogonadism - Thyroid Dysfunction - Bone Diseases, Metabolic1 Location availableCapecitabine and Temozolomide for Neuroendocrine CancersConditions: Neuroendocrine Tumors1 Location availableCixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low- or Intermediate-Grade Neuroendocrine CancerConditions: Extra-Adrenal Paraganglioma - Gastrointestinal Carcinoid Tumor - Head and Neck Cancer - Islet Cell Tumor - Lung Cancer - Neuroendocrine Carcinoma of the Skin - Pheochromocytoma1 Location availableGenetic Study of Patients With Inherited Urologic MalignanciesConditions: Birt Hogg Dube Syndrome - Hereditary Papillary Renal Cell Carcinoma - Kidney Cancer - Multiple Endocrine Neoplasia - Von Hippel-Lindau Syndrome1 Location availableHyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic TumorsConditions: Neuroendocrine Cancer - Small Cell Lung Cancer - Non-Small Cell Lung Cancer - Gastric Cancer1 Location availableVandetanib to Treat Children and Adolescents With Medullary Thyroid CancerConditions: Multiple Endocrine Neoplasia Type 2A - Multiple Endocrine Neoplasia Type 2B1 Location availableStudy Investigating MEN1 and SDHD in Familial Carcinoid TumorsConditions: Carcinoid Neuroendocrine Cancer1 Location availableA Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine TumorsConditions: Gastric Cancer - Pancreatic Cancer3 Locations availableExtension Study of Lapatinib Plus Herceptin With or Without Endocrine TherapyConditions: Breast Cancer1 Location availableEverolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That CConditions: Islet Cell Tumor - Pancreatic Cancer303 Locations availableYttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver MetastasesConditions: Colorectal Neoplasms - Neuroendocrine Tumors - Cholangiocarcinoma - Melanoma - Breast Cancer1 Location availableThe CEASE Study: Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast CancerConditions: Breast Cancer - Arthralgia1 Location availableTissue Procurement for Biomedical ResearchConditions: Cardiovascular Diseases - Cancer - Endocrine Diseases - Neurological Disorders - Arthritis - Mental Disorders1 Location availableStudy of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum CalciumConditions: Breast Cancer - Hypercalcemia of Malignancy - Colon Cancer - Endocrine Cancer - Head and Neck Cancer - Kidney Cancer - Lung Cancer - Lymphoma - Metastatic Cancer - Multiple Myeloma - Parathyroid Neoplasms - Renal Cancer - Thyroid Cancer - Hodgkin's Lympho9 Locations availableComprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological StudiesConditions: Sarcoma - Endocrine Tumors - Neuroblastoma - Retinoblastoma - Renal Cancer2 Locations available68Ga-DOTATATE PET Scan in Neuroendocrine CancerConditions: Neuroendocrine Carcinoma1 Location availableInterleukin-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Treating Patients With Merkel Cell CancerConditions: Recurrent Neuroendocrine Carcinoma of the Skin - Stage I Neuroendocrine Carcinoma of the Skin - Stage II Neuroendocrine Carcinoma of the Skin - Stage III Neuroendocrine Carcinoma of the Skin - Stage IV Neuroendocrine Carcinoma of the Skin1 Location availableStudy to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple MyelomConditions: Multiple Myeloma - Diffuse Large B-Cell Lymphoma - Glioblastoma Multiforme - Hepatocellular Carcinoma - Non-Small Cell Lung Cancer - Gastrointestinal Neuroendocrine Tumors of Non-Pancreatic Origin - Hormone Receptor-Positive Breast Cancer8 Locations availableStudy of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast CancerConditions: Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer11 Locations availableDoxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine TumorsConditions: Gastrointestinal Carcinoid Tumor - Islet Cell Tumor - Metastatic Cancer1 Location availableExtended Endocrine Therapy for Premenopausal Women With Breast CancerConditions: Breast Cancer2 Locations availableSeneca Valley Virus-001 in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine FeaConditions: Adrenocortical Carcinoma - Gastrointestinal Carcinoid Tumor - Kidney Cancer - Neuroblastoma - Retinoblastoma - Sarcoma16 Locations availablePhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast CancerConditions: Metastatic Breast Cancer3 Locations availablePerfusion CT as a Predictor of Treatment Response in Patients With Hepatic MalignanciesConditions: Neuroendocrine Tumors - Brain (Nervous System) Cancers - Colon/Rectal Cancer - Colon Cancer - Hepatobiliary Cancers - Hepatocellular Carcinoma (Hepatoma) - Liver1 Location availableGAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the PancreasConditions: Adenocarcinoma of the Pancreas - Advanced Solid Tumors - Cancer - Cancer of Pancreas - Cancer of the Pancreas - Metastases - Metastatic Cancer - Metastatic Pancreatic Cancer - Pancreas Cancer - Pancreatic Cancer - Bone Metastases - Endocrine Cancer - Onco23 Locations availablePotential Imaging and Molecular Predictors of Response to Novel Therapies in Metastatic Pancreatic Neuroendocrine TumorsConditions: Pancreatic Neuroendocrine Cancer1 Location available
Didn't find what you were looking for? Try these alternatives: